Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association
DT Lackland, EJ Roccella, AF Deutsch, M Fornage… - Stroke, 2014 - Am Heart Assoc
Background and Purpose—Stroke mortality has been declining since the early 20th century.
The reasons for this are not completely understood, although the decline is welcome. As a …
The reasons for this are not completely understood, although the decline is welcome. As a …
Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council …
HP Adams Jr, G Del Zoppo, MJ Alberts, DL Bhatt… - Stroke, 2007 - Am Heart Assoc
Purpose—Our goal is to provide an overview of the current evidence about components of
the evaluation and treatment of adults with acute ischemic stroke. The intended audience is …
the evaluation and treatment of adults with acute ischemic stroke. The intended audience is …
Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years
Background and Purpose—Recombinant tissue-type plasminogen activator (rtPA) is the
only approved therapy for acute ischemic stroke (AIS). In 2004, 1.8% to 2.1% of AIS patients …
only approved therapy for acute ischemic stroke (AIS). In 2004, 1.8% to 2.1% of AIS patients …
Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at get with the guidelines–stroke …
LH Schwamm, SF Ali, MJ Reeves… - … Quality and Outcomes, 2013 - Am Heart Assoc
Background—Substantial efforts over the past decade have increased rates of intravenous
tissue plasminogen activator (tPA) use in the United States. We sought to determine …
tissue plasminogen activator (tPA) use in the United States. We sought to determine …
The epidemiology of admissions of nontraumatic subarachnoid hemorrhage in the United States
BACKGROUND: Subarachnoid hemorrhage (SAH) is the cause of 5% to 10% of strokes
annually in the United States. OBJECTIVE: To study the incidence and mortality trends of …
annually in the United States. OBJECTIVE: To study the incidence and mortality trends of …
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale
AI Qureshi, YY Palesch - Neurocritical care, 2011 - Springer
The December 2003 report from the National Institute of Neurological Disorders and Stroke
(NINDS) Workshop on priorities for clinical research in intracerebral hemorrhage (ICH) …
(NINDS) Workshop on priorities for clinical research in intracerebral hemorrhage (ICH) …
National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate
D Kleindorfer, CJ Lindsell, L Brass, W Koroshetz… - Stroke, 2008 - Am Heart Assoc
Background and Purpose—Current US estimates of recombinant tissue plasminogen
activator (rt-PA) use have been based either on extrapolation of regional studies or on …
activator (rt-PA) use have been based either on extrapolation of regional studies or on …
Transfer delay is a major factor limiting the use of intra-arterial treatment in acute ischemic stroke
Background and Purpose—The development of comprehensive stroke centers within hub-
and-spoke stroke networks offers the opportunity to increase the proportion of acute …
and-spoke stroke networks offers the opportunity to increase the proportion of acute …
Discharge destination as a surrogate for Modified Rankin Scale defined outcomes at 3-and 12-months poststroke among stroke survivors
AI Qureshi, SA Chaudhry, BL Sapkota… - Archives of physical …, 2012 - Elsevier
Qureshi AI, Chaudhry SA, Sapkota BL, Rodriguez GJ, Suri MFK. Discharge destination as a
surrogate for Modified Rankin Scale defined outcomes at 3-and 12-months poststroke …
surrogate for Modified Rankin Scale defined outcomes at 3-and 12-months poststroke …
Bringing the hospital to the patient: first treatment of stroke patients at the emergency site
S Walter, P Kostpopoulos, A Haass, S Helwig, I Keller… - PloS one, 2010 - journals.plos.org
Background Early treatment with rt-PA is critical for favorable outcome of acute stroke.
However, only a very small proportion of stroke patients receive this treatment, as most …
However, only a very small proportion of stroke patients receive this treatment, as most …